Relapsing Multiple Sclerosis (RMS) Recruiting Phase 3 Trials for Rituximab (DB00073)

Also known as: Multiple Sclerosis Relapse / Relapsed Multiple sclerosis / Relapsing Multiple Sclerosis / Multiple sclerosis flare

IndicationStatusPhase
DBCOND0044896 (Relapsing Multiple Sclerosis (RMS))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04047628Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Treatment
NCT04121403Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)Treatment